JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2003; 41:574-581, doi:10.1016/S0735-1097(02)02855-3
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasama, S.
Right arrow Articles by Kurabayashi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kasama, S.
Right arrow Articles by Kurabayashi, M.

Effect of spironolactone on cardiacsympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy

Shu Kasama, MD*,*, Takuji Toyama, MD*, Hisao Kumakura, MD{dagger}, Yoshiaki Takayama, MD{dagger}, Shuichi Ichikawa, MD{dagger}, Tadashi Suzuki, MD* and Masahiko Kurabayashi, MD*

* Second Department of Internal Medicine, Gunma University School of Medicine, MaebashiJapan
{dagger} Kitakanto Cardiovascular Hospital, Gunma, Japan



View larger version (15K):

[in a new window]
 
Figure 1 Cardiac 123I-MIBG uptake was quantified as the H/M ratio 4 h after injection, using regions of interest positioned over the heart (H) and upper mediastinum (M).

 


View larger version (14K):

[in a new window]
 
Figure 2 Segmentation scheme used to quantitate regional 123I-MIBG uptake.

 


View larger version (18K):

[in a new window]
 
Figure 3 Changes in New York Heart Association (NYHA) functional class during treatment in the two groups.

 


View larger version (13K):

[in a new window]
 
Figure 4 Correlation between the changes in the 123I-MIBG scintigraphic findings and changes in left ventricular end-diastolic volume (LVEDV) after six months of spironolactone treatment in 15 patients with dilated cardiomyopathy. Delta LVEDV = LVEDV value after six months – pretreatment value of LVEDV; delta TDS = total defect score (TDS) value after six months – pretreatment value of TDS; delta H/M ratio = H/M ratio after six months – pretreatment value of H/M ratio; delta WR = washout rate (WR) value after six months – pretreatment value of WR.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.